SCIENCE OF
POSSIBILITY
At Vertex, we invest in scientific innovation to create transformative medicines for people with serious diseases.
We've announced the acceptance of the New Drug Application submission to the FDA for our investigational acute pain medication
Vertex reports second quarter 2024 financial results
Vertex announces the FDA has accepted the application and granted Priority Review for our fifth investigational CFTR modulator
We presented new data at the 2024 American Diabetes Association Scientific Sessions on our investigational program for type 1 diabetes
We announced new data at the 2024 European Hematology Association Congress on our treatment for sickle cell disease and beta thalassemia
Working at Vertex
Our company is built on an inclusive culture that brings together the best and brightest in every field striving for one goal: to improve the lives of people with serious diseases.
Find a Vertex clinical trial
Volunteers who participate in clinical trials
help make new medicines a reality.
Featured stories
Our commitment to the sickle cell community extends beyond our research. Learn how we’ve worked with Sickle Cell Warriors to amplify their voices and experiences, highlighting the multifaceted nature of this disease.
Congratulations to our newest Vertex Science Leaders Scholarship recipients.
Learn how we explore the daily lives of those living with debilitating disease to help inform our mission.
Our commitment to the sickle cell community extends beyond our research. Learn how we’ve worked with Sickle Cell Warriors to amplify their voices and experiences, highlighting the multifaceted nature of this disease.
Congratulations to our newest Vertex Science Leaders Scholarship recipients.
Learn how we explore the daily lives of those living with debilitating disease to help inform our mission.
